Healthcare
•3739 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (3739)
| Company | Market Cap | Price |
|---|---|---|
|
NVO
Novo Nordisk A/S
Novo Nordisk is a leading large-cap pharmaceutical company with blockbuster GLP-1 products Wegovy and Ozempic, a core driver of its revenue and growth.
|
$171.07B |
$38.48
-0.04%
|
|
PFE
Pfizer Inc.
Pfizer's vaccines portfolio (e.g., Comirnaty and other RSV vaccines) is a core, revenue-driving product line.
|
$151.35B |
$26.27
-1.33%
|
|
SYK
Stryker Corporation
Orthopedic devices including implants are a core Stryker product category.
|
$146.04B |
$381.92
+0.01%
|
|
DHR
Danaher Corporation
Danaher directly sells diagnostic equipment/instruments (e.g., Cepheid and Beckman Coulter diagnostics platforms like DxC 500i, DXi 9000).
|
$144.61B |
$204.13
-0.29%
|
|
WELL
Welltower Inc.
Healthcare Services & Facilities – Welltower's properties function as healthcare facilities and related operations.
|
$141.97B |
$204.34
-1.21%
|
|
BMY
Bristol-Myers Squibb Company
Opdivo is a monoclonal antibody immuno-oncology therapy, a core direct product in BMY's Growth Portfolio.
|
$126.89B |
$61.06
-2.03%
|
|
HCA
HCA Healthcare, Inc.
HCA operates a large network of hospitals and provides inpatient hospital services.
|
$124.23B |
$544.58
+0.03%
|
|
MDT
Medtronic plc
Medtronic's core cardiovascular devices include leadless pacing, ablation technologies, and related interventional products.
|
$122.56B |
$94.31
-1.34%
|
|
VRTX
Vertex Pharmaceuticals Incorporated
Vertex is a large-cap pharma/biotech with a diversified, revenue-generating portfolio anchored by CFTR modulators and expanding pipeline.
|
$121.25B |
$472.44
-1.14%
|
|
MCK
McKesson Corporation
McKesson distributes medical devices and biometrics through its Medical-Surgical Solutions, aligning with the medical devices category.
|
$120.80B |
$934.11
-4.56%
|
|
BSX
Boston Scientific Corporation
Directly sells Cardiology Devices (e.g., WATCHMAN LAAC, ablation catheters, stents) and other interventional cardiology therapies.
|
$107.05B |
$71.92
-0.39%
|
|
CVS
CVS Health Corporation
CVS Health includes health benefits/insurance via Aetna, a core health insurance offering.
|
$102.28B |
$80.57
|
|
WM
Waste Management, Inc.
WM Healthcare Solutions provides regulated medical waste management and secure information destruction services.
|
$98.28B |
$243.99
+0.02%
|
|
REGN
Regeneron Pharmaceuticals, Inc.
Regeneron’s core business centers on monoclonal antibody therapeutics (e.g., Dupixent, Libtayo).
|
$82.77B |
$776.52
-1.39%
|
|
CI
Cigna Corporation
Health insurance products and related services are CI's core offering.
|
$76.06B |
$281.80
-1.03%
|
|
ELV
Elevance Health Inc.
Direct health insurance provider (Health Insurance) – Elevance Health's core revenue comes from health benefits and risk-sharing with members.
|
$64.77B |
$292.24
+0.27%
|
|
AFL
Aflac Incorporated
Aflac sells health-related supplemental insurance (e.g., cancer insurance) as a core product, aligning with Health Insurance.
|
$58.95B |
$111.61
-0.77%
|
|
MFC
Manulife Financial Corporation
Disability insurance offerings as part of employee benefits/long-term protection.
|
$58.67B |
$34.80
-0.07%
|
|
TAK
Takeda Pharmaceutical Company Limited
Entrvyo/vedolizumab and other monoclonal antibody therapies place Takeda in Monoclonal Antibody Therapeutics.
|
$56.92B |
$18.22
|
Showing page 2 of 38 (3739 total stocks)
Loading company comparison...
Loading industry trends...
Loading research report...
